We are live on ! Find out more
CEROW

CERo Therapeutics Warrants
CEROW

Delisted

CEROW was delisted on the 30th of October, 2025.

Back to rankings

43 hedge funds and large institutions have $478K invested in CERo Therapeutics Warrants in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 9 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 43 → 43 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

78% less capital invested

Capital invested by funds: $2.19M → $478K (-$1.71M)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 9

Holders
43
Holders Change
–
Holders Change %
0%
% of All Funds
0.68%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
9
Closed
1
Calls
$8K
Puts
–
Net Calls
+$8K
Net Calls Change
+$24K

Top Buyers

Rank Fund Capital Flow
1
SCM
Shaolin Capital Management
Florida
+$26.8K

Top Sellers

Rank Fund Capital Flow
1
MP
Mangrove Partners
Connecticut
-$1.78M
2
Parallax Volatility Advisers
Parallax Volatility Advisers
California
-$5.72K
3
SFM
Spartan Fund Management
Canada
-$5.61K
4
SRF
Silver Rock Financial
California
-$779
5
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors
North Carolina
-$547
Name Holding Trade Value Shares
Change 		Change in
Stake
CH
26
CVI Holdings
Delaware
$3.16K -$229 -3,200 -7%
SSA
27
Schonfeld Strategic Advisors
New York
$2.39K -$188 -2,627 -7%
FTUS
28
Flow Traders U.S.
New York
$2K -$281 -3,929 -14%
HF
29
HRT Financial
New York
$2K -$24 -340 -0.9%
Walleye Capital
30
Walleye Capital
New York
$1.86K – – –
SFM
31
Spartan Fund Management
Canada
$1.79K -$5.61K -78,423 -76%
WA
32
Whitebox Advisors
Minnesota
$1.79K – – –
RCM
33
Rivernorth Capital Management
Florida
$1.75K – – –
CAPTRUST Financial Advisors
34
CAPTRUST Financial Advisors
North Carolina
$1.61K -$547 -7,648 -25%
Parallax Volatility Advisers
35
Parallax Volatility Advisers
California
$1.43K -$5.72K -80,000 -80%
GAM
36
Gritstone Asset Management
Maryland
$1.22K – – –
CSS
37
Cubist Systematic Strategies
Connecticut
$1.2K – – –
Walleye Trading
38
Walleye Trading
New York
$965 – – –
Calamos Advisors
39
Calamos Advisors
Illinois
$895 – – –
DCM
40
Dupont Capital Management
Delaware
$895 – – –
SRF
41
Silver Rock Financial
California
$875 -$779 -10,896 -47%
ETH
42
Exos TFP Holdings
New York
$265 – – –
AA
43
Ancora Advisors
Ohio
$179 – – –
RCM
44
Robinson Capital Management
Michigan
$80 -$451 -6,304 -85%
MP
45
Mangrove Partners
Connecticut
– -$1.78M -163,538 Closed
1
2

CEROW Hedge Fund Activity: Q3 2023 in Review

43 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in CERo Therapeutics Warrants (CEROW) for Q3 2023, worth a combined $478K — down 78% from $2.19M a quarter earlier.

Fund positioning in CEROW was balanced in Q3 2023: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 9 trimmed.

The largest buyer was Shaolin Capital Management, opening a new position worth an estimated $26.8K. The largest seller was Mangrove Partners, exiting entirely with an estimated $1.78M sold.

  • 43 institutional investors held CERo Therapeutics Warrants (CEROW) as of Q3 2023, unchanged from Q2 2023.
  • Funds reported $478K of CERo Therapeutics Warrants stock for Q3 2023, down 78% quarter-over-quarter.
  • 1 fund opened new CERo Therapeutics Warrants positions in Q3 2023 and 1 closed out, a net change of 0 holders.
  • The largest CERo Therapeutics Warrants buyer in Q3 2023 was Shaolin Capital Management, an estimated $26.8K added.
  • The largest CERo Therapeutics Warrants seller in Q3 2023 was Mangrove Partners, an estimated $1.78M sold.

Based on aggregated 13F filings for Q3 2023.